Global eCOA, eSource & Clinical Trials 麻豆原创 Research Report 2024

Publication ID:

PB503242859

Publication Date:

March 29, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

They are information technology products for clinical research patient management solutions.
The global eCOA, eSource & Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for eCOA, eSource & Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for eCOA, eSource & Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for eCOA, eSource & Clinical Trials in Contract Research Organizations is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of eCOA, eSource & Clinical Trials include OpenClinica, CRF Health, ERT Clinical, Medidata Solutions, ArisGlobal, ICON plc, PAREXEL International Corporation, Medrio and Medable, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for eCOA, eSource & Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding eCOA, eSource & Clinical Trials.
Report Scope
The eCOA, eSource & Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global eCOA, eSource & Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the eCOA, eSource & Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
OpenClinica
CRF Health
ERT Clinical
Medidata Solutions
ArisGlobal
ICON plc
PAREXEL International Corporation
Medrio
Medable
Oracle
Medpace Holdings
Covance
Bio-Optronics
Segment by Type
On Premise
Cloud-based
Segment by Application
Contract Research Organizations
Hospitals
Pharmaceutical/Biotechnology/Medical Devices Companies
Educational & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of eCOA, eSource & Clinical Trials companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global eCOA, eSource & Clinical Trials 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 On Premise
1.2.3 Cloud-based
1.3 麻豆原创 by Application
1.3.1 Global eCOA, eSource & Clinical Trials 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Contract Research Organizations
1.3.3 Hospitals
1.3.4 Pharmaceutical/Biotechnology/Medical Devices Companies
1.3.5 Educational & Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global eCOA, eSource & Clinical Trials 麻豆原创 Perspective (2019-2030)
2.2 eCOA, eSource & Clinical Trials Growth Trends by Region
2.2.1 Global eCOA, eSource & Clinical Trials 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 eCOA, eSource & Clinical Trials Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 eCOA, eSource & Clinical Trials Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 eCOA, eSource & Clinical Trials 麻豆原创 Dynamics
2.3.1 eCOA, eSource & Clinical Trials Industry Trends
2.3.2 eCOA, eSource & Clinical Trials 麻豆原创 Drivers
2.3.3 eCOA, eSource & Clinical Trials 麻豆原创 Challenges
2.3.4 eCOA, eSource & Clinical Trials 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top eCOA, eSource & Clinical Trials Players by Revenue
3.1.1 Global Top eCOA, eSource & Clinical Trials Players by Revenue (2019-2024)
3.1.2 Global eCOA, eSource & Clinical Trials Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global eCOA, eSource & Clinical Trials 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by eCOA, eSource & Clinical Trials Revenue
3.4 Global eCOA, eSource & Clinical Trials 麻豆原创 Concentration Ratio
3.4.1 Global eCOA, eSource & Clinical Trials 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by eCOA, eSource & Clinical Trials Revenue in 2023
3.5 eCOA, eSource & Clinical Trials Key Players Head office and Area Served
3.6 Key Players eCOA, eSource & Clinical Trials Product Solution and Service
3.7 Date of Enter into eCOA, eSource & Clinical Trials 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 eCOA, eSource & Clinical Trials Breakdown Data by Type
4.1 Global eCOA, eSource & Clinical Trials Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global eCOA, eSource & Clinical Trials Forecasted 麻豆原创 Size by Type (2025-2030)
5 eCOA, eSource & Clinical Trials Breakdown Data by Application
5.1 Global eCOA, eSource & Clinical Trials Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global eCOA, eSource & Clinical Trials Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America eCOA, eSource & Clinical Trials 麻豆原创 Size (2019-2030)
6.2 North America eCOA, eSource & Clinical Trials 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America eCOA, eSource & Clinical Trials 麻豆原创 Size by Country (2019-2024)
6.4 North America eCOA, eSource & Clinical Trials 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe eCOA, eSource & Clinical Trials 麻豆原创 Size (2019-2030)
7.2 Europe eCOA, eSource & Clinical Trials 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe eCOA, eSource & Clinical Trials 麻豆原创 Size by Country (2019-2024)
7.4 Europe eCOA, eSource & Clinical Trials 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific eCOA, eSource & Clinical Trials 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific eCOA, eSource & Clinical Trials 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific eCOA, eSource & Clinical Trials 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific eCOA, eSource & Clinical Trials 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America eCOA, eSource & Clinical Trials 麻豆原创 Size (2019-2030)
9.2 Latin America eCOA, eSource & Clinical Trials 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America eCOA, eSource & Clinical Trials 麻豆原创 Size by Country (2019-2024)
9.4 Latin America eCOA, eSource & Clinical Trials 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa eCOA, eSource & Clinical Trials 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa eCOA, eSource & Clinical Trials 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa eCOA, eSource & Clinical Trials 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa eCOA, eSource & Clinical Trials 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OpenClinica
11.1.1 OpenClinica Company Detail
11.1.2 OpenClinica Business Overview
11.1.3 OpenClinica eCOA, eSource & Clinical Trials Introduction
11.1.4 OpenClinica Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.1.5 OpenClinica Recent Development
11.2 CRF Health
11.2.1 CRF Health Company Detail
11.2.2 CRF Health Business Overview
11.2.3 CRF Health eCOA, eSource & Clinical Trials Introduction
11.2.4 CRF Health Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.2.5 CRF Health Recent Development
11.3 ERT Clinical
11.3.1 ERT Clinical Company Detail
11.3.2 ERT Clinical Business Overview
11.3.3 ERT Clinical eCOA, eSource & Clinical Trials Introduction
11.3.4 ERT Clinical Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.3.5 ERT Clinical Recent Development
11.4 Medidata Solutions
11.4.1 Medidata Solutions Company Detail
11.4.2 Medidata Solutions Business Overview
11.4.3 Medidata Solutions eCOA, eSource & Clinical Trials Introduction
11.4.4 Medidata Solutions Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.4.5 Medidata Solutions Recent Development
11.5 ArisGlobal
11.5.1 ArisGlobal Company Detail
11.5.2 ArisGlobal Business Overview
11.5.3 ArisGlobal eCOA, eSource & Clinical Trials Introduction
11.5.4 ArisGlobal Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.5.5 ArisGlobal Recent Development
11.6 ICON plc
11.6.1 ICON plc Company Detail
11.6.2 ICON plc Business Overview
11.6.3 ICON plc eCOA, eSource & Clinical Trials Introduction
11.6.4 ICON plc Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.6.5 ICON plc Recent Development
11.7 PAREXEL International Corporation
11.7.1 PAREXEL International Corporation Company Detail
11.7.2 PAREXEL International Corporation Business Overview
11.7.3 PAREXEL International Corporation eCOA, eSource & Clinical Trials Introduction
11.7.4 PAREXEL International Corporation Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.7.5 PAREXEL International Corporation Recent Development
11.8 Medrio
11.8.1 Medrio Company Detail
11.8.2 Medrio Business Overview
11.8.3 Medrio eCOA, eSource & Clinical Trials Introduction
11.8.4 Medrio Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.8.5 Medrio Recent Development
11.9 Medable
11.9.1 Medable Company Detail
11.9.2 Medable Business Overview
11.9.3 Medable eCOA, eSource & Clinical Trials Introduction
11.9.4 Medable Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.9.5 Medable Recent Development
11.10 Oracle
11.10.1 Oracle Company Detail
11.10.2 Oracle Business Overview
11.10.3 Oracle eCOA, eSource & Clinical Trials Introduction
11.10.4 Oracle Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.10.5 Oracle Recent Development
11.11 Medpace Holdings
11.11.1 Medpace Holdings Company Detail
11.11.2 Medpace Holdings Business Overview
11.11.3 Medpace Holdings eCOA, eSource & Clinical Trials Introduction
11.11.4 Medpace Holdings Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.11.5 Medpace Holdings Recent Development
11.12 Covance
11.12.1 Covance Company Detail
11.12.2 Covance Business Overview
11.12.3 Covance eCOA, eSource & Clinical Trials Introduction
11.12.4 Covance Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.12.5 Covance Recent Development
11.13 Bio-Optronics
11.13.1 Bio-Optronics Company Detail
11.13.2 Bio-Optronics Business Overview
11.13.3 Bio-Optronics eCOA, eSource & Clinical Trials Introduction
11.13.4 Bio-Optronics Revenue in eCOA, eSource & Clinical Trials Business (2019-2024)
11.13.5 Bio-Optronics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

OpenClinica
CRF Health
ERT Clinical
Medidata Solutions
ArisGlobal
ICON plc
PAREXEL International Corporation
Medrio
Medable
Oracle
Medpace Holdings
Covance
Bio-Optronics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.